NCT01604122View on ClinicalTrials.gov

Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

April 18, 2012

Primary Completion Date

July 27, 2015

Study Completion Date

July 18, 2016

Conditions
Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP)Transthyretin Cardiomyopathy (TTR-CM)Familial Amyloid CardiomyopathySenile Systemic Amyloidosis (SSA)
Interventions
OTHER

No drug

No drug.

OTHER

No drug

No drug.

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01604122 - Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers | Biotech Hunter | Biotech Hunter